一、近10年发表SCI论文

1. Ji YY, Bao K, Mei L, Su YH, Wu YK, Li C, Wu YS, Ge ZS, Choi SK, Wang ZD*, Choi HS. Dual-channel NIR fluorescence imaging for precise delineation of gastric tumor margins. Biomaterials Research, 2025, 29:0275.(SCI, IF: 9.6)

2. Mourdi N, Wu YK, Su YH, Zhao YY, Jin X, Li YH, Wang ZD*. The role of indocyanine green in the intraoperative navigation of gastric cancer surgery: a systematic review and meta-analysis. BMC Cancer.2025,25(1):1920. (SCI, IF: 3.4)

3. Wu YK, Su YH, Zhao YY, Mourdi N, Wang ZD*. Precision of predictive nomograms for lymph node metastasis of thyroid cancer from Chinese real-world study: a systematic review and meta-analysis. Frontiers in Endocrinology. 2025,16:1617563.(SCI, IF:4.6)

4. Li C, Wang ZD*, Ge ZS*. Stimuli-responsive polymeric nanoprobes for bioimaging of cancer metastasis. Macromol Biosci. 2025,25(9):e00168. (SCI, IF:4.1)

5. Jiang TT, Su YH, Wu YK, Li C, Sun TK, Li YH, Ji YY, Wang ZD. No closure of the linea alba cervicalis reduces complications in endoscopic thyroidectomy. Sci Rep, 2025, 15(1): 4577. (SCI, IF: 3.8)

6. Su YH, Mei L, Wu YK, Li C, Jiang TT, Zhao YY, Feng X, Sun TK, Li YH, Wang ZD, Ji YY. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of papillary thyroid carcinoma via the BRAF-ERK1/2-P53 signaling pathway. J Endocrinol Invest, 2024. doi: 10.1007/s40618-024-02481-5.(SCI, K8E7P, IF: 5.4)

7. Su YH, Wu YK, Li C, Sun TK, Li YH, Wang ZD. Sarcopenia among treated cancer patients before and after neoadjuvant chemotherapy: a systematic review and meta‐analysis of  high-quality studies. Clin Transl Oncol, 2024, 26:1844–1855.(SCI, ZA4F0, IF: 3.4)
8. Su YH, Wu YK, Li C, Zhao YY, Li YH, Jing X, Wang ZD. Significance of sarcopenia in elderly patients undergoing endoscopic submucosal dissection: a systematic review and meta-analysis. Dig Dis Sci, 2024, 69:2970–2984. (SCI, D5O1M, IF: 3.1)
9. Su YH, Mei L, Jiang TT, Wang ZD, Ji YY. Novel role of lncRNAs regulatory network in papillary thyroid cancer. Biochem Biophys Rep, 2024, 38: 101674. (SCI, OR8B9, IF: 2.8)
10. Wu YK, Jiang TT, Su YH, Mei L, Sun TK, Li YH, Wang ZD, Ji YY. The potential role of virus infection in the progression of thyroid cancer.World J Oncol, 2024,15(3): 382-393. (SCI, RO1N4, IF: 5.2)
11. Wang ZD, Mei L, Yang X, Jiang TT, Sun TK, Su YH, Wu YS, Ji YY. Near-infrared fluorophores methylene blue for targeted imaging of the stomach in intraoperative navigation. Front Bioeng and Biotechnol, 2023, 11: 1172073. (SCI, E7QX3, IF: 6.064)
12. Nomura S, Yokomizo S, Wang ZD , Kang H, Bao K, Yang CG, Rubin B, Bronson R, Kashiwagi S, Choi HS. CD117-targeted intraoperative imaging of gastrointestinal stromal tumor using a stem-cell-factor-labeled fluorophore. Adv Nanobiomed Res, 2023, 12: 202300063.. (SCI, Z0BK9, IF: 3.4)
13. Wang ZD, Yang X, Mei L, Jiang TT, Sun TK, Chen HY, Wu YS, Ji YY. Indocyanine green for targeted  imaging of the gall bladder and fluorescence navigation. J Biophotonics, 2022, 15(11): e202200142. (SCI, 5X0OC, IF: 3.39)
14. Jiang TT, Mei L, Yang X, Sun TK, Wang ZD, Ji YY. Biomarkers of gastric cancer: current advancement. Heliyon, 2022, 8: e10899. (SCI, 5O6DE, IF:3.776)
15. Ji YY, Jiang TT, Sun TK, Wang ZD. long-term colorectal cancer incidence and mortality after adenoma removal associated with heritable factors,colonoscopic surveillance and aspirin. Aliment Pharmacol Ther, 2022, 55(10):1361-1362. (SCI, 0U0VL, IF:9.524)
16. Ji YY, Chen HY, Gou W, Ma L, Jin YF, Hui B, Yang ZA, Wang ZD. Potential biomarkers Ang II/AT1R and S1P/S1PR1 predict the prognosis of hepatocellular carcinoma. Oncol Lett, 2020, 20(5): 208. (SCI, OS4ZJ, IF:3.111)
17. Ji YY, Wang ZD, Bao K, Park GK, Kang HM, Hu S, McDonald E, Kim MS, Kashiwagi S, Choi HS. Targeted molecular imaging of TLR4 in hepatocellular carcinoma using zwitterionic near-infrared fluorophores. Quant Imaging Med Surg, 2019, 9(9): 1548-1555. (SCI, JB3IK, IF: 4.63)
18. Ji YY, Wang ZD, Chen HY, Zhang L, Zhuo F, Yang QQ. Chronic hepatitis B patients serum promotes growth and proliferation via IGF-II/IGF-1R/MEK/ERK signaling pathway in hepatocellular carcinomacells. Cell Physiol Biochem, 2018, 47: 39-53. ( SCI, GI8SI, IF: 5.5) 
19. Ji YY, Wang ZD, Li ZF, Huang N, Chen HY, Li BH, Hui B. Silencing IGF-II impairs C-myc and N-ras expressions of SMMC-7721 cells via suppressing FAK/PI3K/Akt signaling pathway. Cytokine, 2017, 90: 44-53. ( SCI, EL1QM, IF:3.488)
20. Ji YY, Wang ZD, Li ZF, Zhang AJ, Jin YF, Chen HY, Le XF. Angiotensin II enhances proliferation and inflammation through AT1/PKC/NF-κB signaling pathway in hepatocellular carcinoma cells.Cell Physiol Biochem, 2016, 39(1):13-32. ( SCI, DP9BI, IF: 5.5)
21. Ji YY, Zhang AJ, Chen XB, Che XX, Zhou K, Wang ZD. Sodium humate accelerates cutaneous wound healing by activating TGF-β/Smads signaling pathway in rats. Acta Pharm Sin B, 2016,6(2):132-140. ( SCI, DG3RQ, IF: 6.014)
22. Ji YY, Wang ZD, Wang SF, Wang BT, Yang ZA, Zhou XR, Lei NN, Yue WN. Ischemic preconditioning ameliorates intestinal injury induced by ischemia-reperfusion in rats. World J Gastroenterol, 2015, 21(26): 8081-8088. ( SCI, CM5SR, IF: 3.365) 
23. Wang ZD, Ji YY,Wang SF, Wang R, Li ZF, Kang AJ, Xu HL, Shi M, Zhao MX. Protective effect of intestinal ischemic preconditioning on ischemia reperfusion-caused lung injury in rats. Inflammation, 2015, 38(1): 424-432. ( SCI, CA6IS, IF: 2.955)  
24. Ji YY, Wang ZD, Li ZF. Smoking cessation, weight change, and risk of cardiovascular disease. JAMA, 2013, 310(3): 322-322. ( SCI, 183RU, IF: 44.405)
25. Ji YY, Wang ZD, Li ZF, Li K. Interference of suppressor of cytokine signaling 3 promotes epithelial-mesenchymal transition in MHCC97H cells. World J Gastroentero, 2013, 19(6): 866-873. ( SCI, 084UY, IF: 3.365) 

26. Wang ZD, Ji YY, Li ZF. Multivitamins for cancer prevention in men. JAMA, 2013, 309(10): 980-980. ( SCI, 103SH, IF: 44.405)

二、获得学术奖励

1. 原发性肝癌综合治疗的基础与临床研究，陕西省人民政府，陕西省科学技术一等奖（2014, R4）。
2. 第十二届陕西省自然科学优秀论文奖，陕西省人民政府（2013，R1）。